Subscribe To
cerevel therapeutics to report third quarter 2023 financial results and business updates on wednesday, november 1, 2023
CAMBRIDGE, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) — cerevel Therapeutics (Nasdaq: CERE), a company ded...
October 13, 2023, 10:30 am
cerevel therapeutics to report third quarter 2023 financial results and business updates on wednesday, november 1, 2023
CAMBRIDGE, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) -- cerevel Therapeutics (Nasdaq: CERE), a company dedi...
October 13, 2023, 6:30 am
cerevel therapeutics announces pricing of $450 million public offering of common stock
CAMBRIDGE, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) — cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE)...
October 12, 2023, 2:45 am
cerevel therapeutics to present at morgan stanley 21st annual global healthcare conference
CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- cerevel Therapeutics, (Nasdaq: CERE), a company ded...
August 29, 2023, 6:30 am
Why shares of cerevel therapeutics are dropping wednesday
cerevel said it is experiencing delays in some of its clinical trials. The company appointed a new CEO ...
August 2, 2023, 10:47 am
cerevel therapeutics to report second quarter 2023 financial results and business updates on wednesday, august 2, 2023
CAMBRIDGE, Mass., July 05, 2023 (GLOBE NEWSWIRE) -- cerevel Therapeutics (Nasdaq: CERE), a company dedi...
July 5, 2023, 6:30 am
cerevel: high priced stock doing interesting science
cerevel has some interesting data in various CNS indications. However, the company has a very high valu...
June 4, 2023, 6:38 am
cerevel therapeutics appoints susan altschuller, ph.d. as chief financial officer
Susan Altschuller, Ph.D. brings financial management, investor relations, and business planning experience from leading pharmaceutical and biotechnolo...
May 10, 2023, 10:30 am
cerevel therapeutics holdings, inc. (cere) q1 2023 earnings call transcript
cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE ) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM...
May 7, 2023, 5:12 am
cerevel therapeutics to report fourth quarter and full year 2022 financial results and business updates on wednesday, february 22, 2023
CAMBRIDGE, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) -- cerevel Therapeutics (Nasdaq: CERE), a company dedi...
February 1, 2023, 6:30 am
cerevel therapeutics to present at 41st annual j.p. morgan healthcare conference and provide pipeline update
Initiated Phase 1 healthy volunteer trial to support development of emraclidine in Alzheimer's disease psychosis in Q4 2022; second potential indicati...
January 9, 2023, 6:30 am
cerevel therapeutics to present at the 41st annual j.p. morgan healthcare conference
CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- cerevel Therapeutics, (Nasdaq: CERE), a company ded...
January 4, 2023, 6:30 am
cerevel therapeutics holdings, inc. (cere) q3 2022 earnings call transcript
cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE ) Q3 2022 Earnings Conference Call November 8, 2022 8:...
November 13, 2022, 12:43 am
cerevel therapeutics to present at upcoming investor conferences
CAMBRIDGE, Mass., Nov. 11, 2022 (GLOBE NEWSWIRE) — cerevel Therapeutics, (Nasdaq: CERE), a company de...
November 11, 2022, 11:30 am
cerevel therapeutics to present at upcoming investor conferences
CAMBRIDGE, Mass., Nov. 11, 2022 (GLOBE NEWSWIRE) -- cerevel Therapeutics, (Nasdaq: CERE), a company ded...
November 11, 2022, 6:30 am
Why cerevel therapeutics (cere) might surprise this earnings season
cerevel Therapeutics (CERE) is seeing favorable earnings estimate revision activity and has a positive ...
November 7, 2022, 11:38 am
cerevel therapeutics holdings, inc. (cere) ceo tony coles on q2 2022 results - earnings call transcript
cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE ) Q2 2022 Earnings Conference Call August 1, 2022 8:00...
August 1, 2022, 2:30 pm
cerevel therapeutics to present at the jefferies healthcare conference
CAMBRIDGE, Mass., May 25, 2022 (GLOBE NEWSWIRE) -- cerevel Therapeutics (Nasdaq: CERE), a company dedic...
May 25, 2022, 6:30 am
cerevel therapeutics holdings, inc. (cere) ceo tony coles on q1 2022 results - earnings call transcript
cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE ) Q1 2022 Earnings Conference Call May 10, 2022 8:00 A...
May 14, 2022, 3:59 pm
cerevel therapeutics to present at the stifel 4th annual cns day event
CAMBRIDGE, Mass., March 21, 2022 (GLOBE NEWSWIRE) -- cerevel Therapeutics (Nasdaq: CERE), a company ded...
March 21, 2022, 6:30 am